Literature DB >> 23090439

Incidence and risk factors for reoperation of surgically treated urinary incontinence.

Patrick Dällenbach1, Carine Luyet, Carol Jungo Nancoz, Michel Boulvain.   

Abstract

INTRODUCTION AND HYPOTHESIS: The objective of our study was to estimate the incidence and to identify the risk factors for reoperation of surgically treated stress urinary incontinence (SUI).
METHODS: We conducted a nested case-control study among 1,132 women who underwent SUI surgery from January 1988 to June 2007. Cases (n=35) were women who required reoperation for SUI following the first intervention up to December 2008. Controls (n=89) were women randomly selected from the same cohort who did not require reoperation.
RESULTS: The cumulative incidence of SUI reoperation was 3.1 % with a mean follow-up of 10.9 years (range 1.7-21.0). The main risk factor was the history of more than one vaginal delivery [adjusted odds ratio (OR) 3.5; 95 % confidence interval (CI) 1.0-12.6]. The use of synthetic midurethral slings was a protective factor compared to other surgical procedures for urinary incontinence (adjusted OR 0.1; 95 % CI 0.0-0.6).
CONCLUSIONS: The risk of reoperation after SUI surgery appears to be low and associated with multiple vaginal deliveries. Synthetic slings at index surgery are associated with a lower risk of reoperation.

Entities:  

Mesh:

Year:  2012        PMID: 23090439     DOI: 10.1007/s00192-012-1969-7

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  16 in total

1.  Reoperation 10 years after surgically managed pelvic organ prolapse and urinary incontinence.

Authors:  Mary Anna Denman; W Thomas Gregory; Sarah H Boyles; Virginia Smith; S Renee Edwards; Amanda L Clark
Journal:  Am J Obstet Gynecol       Date:  2008-03-20       Impact factor: 8.661

2.  Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings.

Authors:  Matthew D Barber; Steven Kleeman; Mickey M Karram; Marie Fidela R Paraiso; Mark Ellerkmann; Sandip Vasavada; Mark D Walters
Journal:  Am J Obstet Gynecol       Date:  2008-12       Impact factor: 8.661

3.  Risk factors for failure of retropubic and transobturator midurethral slings.

Authors:  R Marijn Houwert; Pieter L Venema; Annelies E Aquarius; Hein W Bruinse; Jan Paul W R Roovers; Harry A M Vervest
Journal:  Am J Obstet Gynecol       Date:  2009-06-26       Impact factor: 8.661

4.  Surgical treatment of female urinary stress incontinence.

Authors:  A Ingelman-Sundberg; U Ulmsten
Journal:  Contrib Gynecol Obstet       Date:  1983

5.  Prevalence and trends of urinary incontinence in adults in the United States, 2001 to 2008.

Authors:  Alayne D Markland; Holly E Richter; Chyng-Wen Fwu; Paul Eggers; John W Kusek
Journal:  J Urol       Date:  2011-08       Impact factor: 7.450

6.  Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence.

Authors:  A L Olsen; V J Smith; J O Bergstrom; J C Colling; A L Clark
Journal:  Obstet Gynecol       Date:  1997-04       Impact factor: 7.661

7.  The very obese woman and the very old woman: tension-free vaginal tape for the treatment of stress urinary incontinence.

Authors:  Dan Hellberg; Corinne Holmgren; Lars Lanner; Staffan Nilsson
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-07-26

8.  Risk factors of treatment failure of midurethral sling procedures for women with urinary stress incontinence.

Authors:  Kobi Stav; Peter L Dwyer; Anna Rosamilia; Lore Schierlitz; Yik N Lim; Joseph Lee
Journal:  Int Urogynecol J       Date:  2009-10-24       Impact factor: 2.894

9.  Reoperation for urinary incontinence.

Authors:  Michael Fialkow; Rebecca Gaston Symons; David Flum
Journal:  Am J Obstet Gynecol       Date:  2008-07-17       Impact factor: 8.661

10.  Primary and repeat surgical treatment for female pelvic organ prolapse and incontinence in parous women in the UK: a register linkage study.

Authors:  Mohamed Abdel-Fattah; Akinbowale Familusi; Shona Fielding; John Ford; Sohinee Bhattacharya
Journal:  BMJ Open       Date:  2011-11-14       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.